Allosteric MEK1/2 inhibitors including cobimetanib and trametinib in the treatment of cutaneous melanomas

Title
Allosteric MEK1/2 inhibitors including cobimetanib and trametinib in the treatment of cutaneous melanomas
Authors
Keywords
Catalytic spine, ERK1/2, K/E/D/D, Raf, Ras, Regulatory spine
Journal
PHARMACOLOGICAL RESEARCH
Volume 117, Issue -, Pages 20-31
Publisher
Elsevier BV
Online
2016-12-10
DOI
10.1016/j.phrs.2016.12.009

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now